Atlas Venture Life Science Advisors, LLC
Position in KYMR — Kymera Therapeutics, Inc.
CIK 1917529
CAMBRIDGE, MA
Position in KYMR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$326,527,526
-$54,774,760 QoQ
Shares Held
2,847,541
-37.8% QoQ
Ownership
3.42%
of shares outstanding
% of Portfolio
37.05%
of 13F equity value
Holder Rank
#12
of 273 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KYMR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Atlas Venture Life Science Advisors, LLC holds $881,289,155 across 7 Biotechnology names. KYMR ranks #1 (37.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KYMR |
Kymera Therapeutics, Inc.
This page
|
2,847,541 | $326,527,526 | |
| 2 | DYN |
Dyne Therapeutics, Inc.
|
6,800,099 | $151,030,198 | |
| 3 | SION |
Sionna Therapeutics, Inc.
|
2,995,602 | $131,776,531 | |
| 4 | KLRA |
Kailera Therapeutics, Inc.
|
5,171,282 | $113,923,342 | |
| 5 | IRON |
Disc Medicine, Inc.
|
1,513,875 | $110,724,817 | |
| 6 | QTTB |
Q32 Bio Inc.
|
2,717,106 | $34,615,930 | |
| 7 | KRRO |
Korro Bio, Inc.
|
962,884 | $12,690,811 |
All Filings in KYMR
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $326,527,526 | 2,847,541 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $381,302,286 | 4,578,008 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $362,584,795 | 4,659,874 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $277,139,749 | 4,896,462 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $213,681,601 | 4,896,462 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $134,016,164 | 4,896,462 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $196,984,666 | 4,896,462 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $231,749,546 | 4,896,462 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $159,710,096 | 5,350,422 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $216,169,952 | 5,377,362 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $149,151,350 | 5,858,262 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $81,429,841 | 5,858,262 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $134,681,443 | 5,858,262 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $173,580,303 | 5,858,262 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $149,379,010 | 5,984,736 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $149,683,945 | 6,875,698 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $135,382,493 | 6,875,698 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $290,979,539 | 6,875,698 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $436,538,066 | 6,875,698 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||